Allan Reine serves as Executive at PIERIS PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Allan Reine has executed 3 insider transactions totaling $313.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 9, 2021 involved exercising options for 26,892 shares valued at $100.0K.
Allan Reine currently holds 53,784 shares of PIERIS PHARMACEUTICALS, INC. (PIRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allan Reine has been a net buyer of PIRS stock. They have purchased $313.4K and sold $0 worth of shares.
Allan Reine's most recent insider trade was on Aug 9, 2021, when they sold 26,892 shares at $3.72 per share.
Get notified when new Form 4 filings are submitted
| $4.89 |
| Discretionary |
| Aug 16, 2017 | PIRS | $215.6K | Purchase | 45,000 | $4.79 | Discretionary |